Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rosano

Showing results (171-180 of 370) with videos related to

Pageof 37
Sort By:
JACC. Heart Failure|February 12, 2018
Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEFGianluigi Savarese, Nicola Orsini, Camilla Hage, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2021
Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure RegistryChris J Kapelios, Lars H Lund, Lina Benson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2022
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysisGiulia Ferrannini, Lars H Lund, Lina Benson, et al.
Journal of Molecular Biology|December 31, 2003
beta2-microglobulin H31Y variant 3D structure highlights the protein natural propensity towards intermolecular aggregationC Rosano, S Zuccotti, P Mangione, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 16, 2009
Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal womenGiuseppe M C Rosano, Silvia Maffei, Maria G Andreassi, et al.
The American Journal of Cardiology|December 7, 2010
Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failureGiuseppe Marazzi, Ferdinando Iellamo, Maurizio Volterrani, et al.
Current Medicinal Chemistry|July 19, 2013
Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cellsA A Amaro, A I Esposito, V Mirisola, et al.
Protein Science : a Publication of the Protein Society|May 4, 2000
Oxygen binding by alpha(Fe2+)2beta(Ni2+)2 hemoglobin crystalsS Bruno, S Bettati, M Manfredini, et al.
International Journal of Cardiology|January 18, 2006
Effect of estradiol 17beta upon coronary artery vasoconstrictor response to methylergometrine maleate in female menopausal patientsGiuseppe M C Rosano, Peter Collins, Otavio Gerbara, et al.
Current Pharmaceutical Design|January 9, 2009
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunctionMassimiliano Caprio, Caterina Mammi, Iris Z Jaffe, et al.
Pageof 37

Showing results (171-180 of 370) with videos related to

Sort By:
Pageof 37
JACC. Heart Failure|February 12, 2018
Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEFGianluigi Savarese, Nicola Orsini, Camilla Hage, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2021
Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure RegistryChris J Kapelios, Lars H Lund, Lina Benson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2022
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysisGiulia Ferrannini, Lars H Lund, Lina Benson, et al.
Journal of Molecular Biology|December 31, 2003
beta2-microglobulin H31Y variant 3D structure highlights the protein natural propensity towards intermolecular aggregationC Rosano, S Zuccotti, P Mangione, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 16, 2009
Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal womenGiuseppe M C Rosano, Silvia Maffei, Maria G Andreassi, et al.
The American Journal of Cardiology|December 7, 2010
Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failureGiuseppe Marazzi, Ferdinando Iellamo, Maurizio Volterrani, et al.
Current Medicinal Chemistry|July 19, 2013
Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cellsA A Amaro, A I Esposito, V Mirisola, et al.
Protein Science : a Publication of the Protein Society|May 4, 2000
Oxygen binding by alpha(Fe2+)2beta(Ni2+)2 hemoglobin crystalsS Bruno, S Bettati, M Manfredini, et al.
International Journal of Cardiology|January 18, 2006
Effect of estradiol 17beta upon coronary artery vasoconstrictor response to methylergometrine maleate in female menopausal patientsGiuseppe M C Rosano, Peter Collins, Otavio Gerbara, et al.
Current Pharmaceutical Design|January 9, 2009
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunctionMassimiliano Caprio, Caterina Mammi, Iris Z Jaffe, et al.
Pageof 37